Ramucirumab

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Product Details
Company Profile

Min.Order :0
Purity: ≥98%

Keywords

Cyramza Imc 1121b

Quick Details

Appearance:
Application:antitumor agent
PackAge:
ProductionCapacity:
Storage:Store at -20°C
Transportation:

Superiority:

We provide customized and high-quality Ramucirumab product for your project.

Details:

Ramucirumab is a human IgG1 monoclonal antibody developed by ImClone Systems Inc to treat solid tumors. It has been approved by FDA for the treatment of advanced gastric or gastro-esophageal junction adenocarcinoma and metastatic non-small-cell lung carcinoma (NSCLC). Ramucirumab acts as a VEGFR2 antagonist via binding to VEGFR2.

View All